Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Memory T cell subsets in healthy gingiva and periodontitis tissues.

Mahanonda R, Champaiboon C, Subbalekha K, Sa-Ard-Iam N, Yongyuth A, Isaraphithakkul B, Rerkyen P, Charatkulangkun O, Pichyangkul S.

J Periodontol. 2018 Sep;89(9):1121-1130. doi: 10.1002/JPER.17-0674. Epub 2018 Aug 16.

PMID:
29790576
2.

Chemoprophylaxis with sporozoite immunization in P. knowlesi rhesus monkeys confers protection and elicits sporozoite-specific memory T cells in the liver.

Pichyangkul S, Spring MD, Yongvanitchit K, Kum-Arb U, Limsalakpetch A, Im-Erbsin R, Ubalee R, Vanachayangkul P, Remarque EJ, Angov E, Smith PL, Saunders DL.

PLoS One. 2017 Feb 9;12(2):e0171826. doi: 10.1371/journal.pone.0171826. eCollection 2017.

3.

Human Memory B Cells in Healthy Gingiva, Gingivitis, and Periodontitis.

Mahanonda R, Champaiboon C, Subbalekha K, Sa-Ard-Iam N, Rattanathammatada W, Thawanaphong S, Rerkyen P, Yoshimura F, Nagano K, Lang NP, Pichyangkul S.

J Immunol. 2016 Aug 1;197(3):715-25. doi: 10.4049/jimmunol.1600540. Epub 2016 Jun 22.

4.

Antibody profiles to plasmodium merozoite surface protein-1 in Cambodian adults during an active surveillance cohort with nested treatment study.

Spring MD, Pichyangkul S, Lon C, Gosi P, Yongvanichit K, Srichairatanakul U, Limsalakpeth A, Chaisatit C, Chann S, Sriwichai S, Auayapon M, Chaorattanakawee S, Dutta S, Prom S, Meng Chour C, Walsh DS, Angov E, Saunders DL.

Malar J. 2016 Jan 8;15:17. doi: 10.1186/s12936-015-1058-8.

5.

Tissue Distribution of Memory T and B Cells in Rhesus Monkeys following Influenza A Infection.

Pichyangkul S, Yongvanitchit K, Limsalakpetch A, Kum-Arb U, Im-Erbsin R, Boonnak K, Thitithayanont A, Jongkaewwattana A, Wiboon-ut S, Mongkolsirichaikul D, Mahanonda R, Spring M, Chuang I, Mason CJ, Saunders DL.

J Immunol. 2015 Nov 1;195(9):4378-86. doi: 10.4049/jimmunol.1501702. Epub 2015 Sep 25.

6.

Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.

Spring MD, Lin JT, Manning JE, Vanachayangkul P, Somethy S, Bun R, Se Y, Chann S, Ittiverakul M, Sia-ngam P, Kuntawunginn W, Arsanok M, Buathong N, Chaorattanakawee S, Gosi P, Ta-aksorn W, Chanarat N, Sundrakes S, Kong N, Heng TK, Nou S, Teja-isavadharm P, Pichyangkul S, Phann ST, Balasubramanian S, Juliano JJ, Meshnick SR, Chour CM, Prom S, Lanteri CA, Lon C, Saunders DL.

Lancet Infect Dis. 2015 Jun;15(6):683-91. doi: 10.1016/S1473-3099(15)70049-6. Epub 2015 Apr 12.

PMID:
25877962
7.

Pre-existing cross-reactive antibodies to avian influenza H5N1 and 2009 pandemic H1N1 in US military personnel.

Pichyangkul S, Krasaesub S, Jongkaewwattana A, Thitithanyanont A, Wiboon-Ut S, Yongvanitchit K, Limsalakpetch A, Kum-Arb U, Mongkolsirichaikul D, Khemnu N, Mahanonda R, Garcia JM, Mason CJ, Walsh DS, Saunders DL.

Am J Trop Med Hyg. 2014 Jan;90(1):149-52. doi: 10.4269/ajtmh.13-0151. Epub 2013 Nov 25.

8.

Comparison of the immune responses induced by soluble and particulate Plasmodium vivax circumsporozoite vaccine candidates formulated in AS01 in rhesus macaques.

Vanloubbeeck Y, Pichyangkul S, Bayat B, Yongvanitchit K, Bennett JW, Sattabongkot J, Schaecher K, Ockenhouse CF, Cohen J, Yadava A; P. vivax vaccine study group.

Vaccine. 2013 Dec 16;31(52):6216-24. doi: 10.1016/j.vaccine.2013.10.041. Epub 2013 Oct 19.

PMID:
24144477
9.

Generation and preclinical evaluation of a DENV-1/2 prM+E chimeric live attenuated vaccine candidate with enhanced prM cleavage.

Keelapang P, Nitatpattana N, Suphatrakul A, Punyahathaikul S, Sriburi R, Pulmanausahakul R, Pichyangkul S, Malasit P, Yoksan S, Sittisombut N.

Vaccine. 2013 Oct 17;31(44):5134-40. doi: 10.1016/j.vaccine.2013.08.027. Epub 2013 Aug 22.

PMID:
23973247
10.

Protective efficacy of baculovirus dual expression system vaccine expressing Plasmodium falciparum circumsporozoite protein.

Iyori M, Nakaya H, Inagaki K, Pichyangkul S, Yamamoto DS, Kawasaki M, Kwak K, Mizukoshi M, Goto Y, Matsuoka H, Matsumoto M, Yoshida S.

PLoS One. 2013 Aug 12;8(8):e70819. doi: 10.1371/journal.pone.0070819. eCollection 2013.

11.

Evaluation of in vitro cross-reactivity to avian H5N1 and pandemic H1N1 2009 influenza following prime boost regimens of seasonal influenza vaccination in healthy human subjects: a randomised trial.

Bethell D, Saunders D, Jongkaewwattana A, Kramyu J, Thitithayanont A, Wiboon-ut S, Yongvanitchit K, Limsalakpetch A, Kum-Arb U, Uthaimongkol N, Garcia JM, Timmermans AE, Peiris M, Thomas S, Engering A, Jarman RG, Mongkolsirichaikul D, Mason C, Khemnu N, Tyner SD, Fukuda MM, Walsh DS, Pichyangkul S.

PLoS One. 2013;8(3):e59674. doi: 10.1371/journal.pone.0059674. Epub 2013 Mar 26.

12.

MxA expression induced by α-defensin in healthy human periodontal tissue.

Mahanonda R, Sa-Ard-Iam N, Rerkyen P, Thitithanyanont A, Subbalekha K, Pichyangkul S.

Eur J Immunol. 2012 Apr;42(4):946-56. doi: 10.1002/eji.201141657.

13.

A single injection of 19 kda carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 (PyMSP1(19)) formulated with Montanide ISA and CpG ODN induces protective immune response in mice.

Hirunpetcharat C, Mahakunkijcharoen Y, Jeamwattanalert P, Kittigul L, Mahannop P, Pichyangkul S.

Asian Pac J Allergy Immunol. 2011 Sep;29(3):252-9.

14.

Evaluation of the safety and immunogenicity in rhesus monkeys of a recombinant malaria vaccine for Plasmodium vivax with a synthetic Toll-like receptor 4 agonist formulated in an emulsion.

Lumsden JM, Pichyangkul S, Srichairatanakul U, Yongvanitchit K, Limsalakpetch A, Nurmukhambetova S, Klein J, Bertholet S, Vedvick TS, Reed SG, Sattabongkot J, Bennett JW, Polhemus ME, Ockenhouse CF, Howard RF, Yadava A.

Infect Immun. 2011 Sep;79(9):3492-500. doi: 10.1128/IAI.05257-11. Epub 2011 Jun 20.

15.

Innate antiviral immunity of periodontal tissue.

Mahanonda R, Sa-Ard-Iam N, Rerkyen P, Champaiboon C, Vanavit N, Pichyangkul S.

Periodontol 2000. 2011 Jun;56(1):143-53. doi: 10.1111/j.1600-0757.2010.00378.x. Review. No abstract available.

PMID:
21501241
16.

Department of Defense influenza and other respiratory disease surveillance during the 2009 pandemic.

Burke RL, Vest KG, Eick AA, Sanchez JL, Johns MC, Pavlin JA, Jarman RG, Mothershead JL, Quintana M, Palys T, Cooper MJ, Guan J, Schnabel D, Waitumbi J, Wilma A, Daniels C, Brown ML, Tobias S, Kasper MR, Williams M, Tjaden JA, Oyofo B, Styles T, Blair PJ, Hawksworth A, Montgomery JM, Razuri H, Laguna-Torres A, Schoepp RJ, Norwood DA, Macintosh VH, Gibbons T, Gray GC, Blazes DL, Russell KL; AFHSC-GEIS Influenza Surveillance Writing Group, Rubenstein J, Hathaway K, Gibbons R, Yoon IK, Saunders D, Gaywee J, Stoner M, Timmermans A, Shrestha SK, Velasco JM, Alera MT, Tannitisupawong D, Myint KS, Pichyangkul S, Woods B, Jerke KH, Koenig MG, Byarugaba DK, Mangen FW, Assefa B, Williams M, Brice G, Mansour M, Pimentel G, Sebeny P, Talaat M, Saeed T, Espinosa B, Faix D, Maves R, Kochel T, Smith J, Guerrero A, Maupin G, Sjoberg P, Duffy M, Garner J, Canas L, Macias E, Kuschner RA, Shanks D, Lewis S, Nowak G, Ndip LM, Wolfe N, Saylors K.

BMC Public Health. 2011 Mar 4;11 Suppl 2:S6. doi: 10.1186/1471-2458-11-S2-S6. Review.

17.

Antiviral immune responses in H5N1-infected human lung tissue and possible mechanisms underlying the hyperproduction of interferon-inducible protein IP-10.

Thitithanyanont A, Engering A, Uiprasertkul M, Ekchariyawat P, Wiboon-Ut S, Kraivong R, Limsalakpetch A, Kum-Arb U, Yongvanitchit K, Sa-Ard-Iam N, Rukyen P, Mahanonda R, Kawkitinarong K, Auewarakul P, Utaisincharoen P, Sirisinha S, Mason CJ, Fukuda MM, Pichyangkul S.

Biochem Biophys Res Commun. 2010 Aug 6;398(4):752-8. doi: 10.1016/j.bbrc.2010.07.017. Epub 2010 Jul 11.

18.

Evaluation of the safety and immunogenicity of Plasmodium falciparum apical membrane antigen 1, merozoite surface protein 1 or RTS,S vaccines with adjuvant system AS02A administered alone or concurrently in rhesus monkeys.

Pichyangkul S, Tongtawe P, Kum-Arb U, Yongvanitchit K, Gettayacamin M, Hollingdale MR, Limsalakpetch A, Stewart VA, Lanar DE, Dutta S, Angov E, Ware LA, Bergmann-Leitner ES, House B, Voss G, Dubois MC, Cohen JD, Fukuda MM, Heppner DG, Miller RS.

Vaccine. 2009 Dec 11;28(2):452-62. doi: 10.1016/j.vaccine.2009.10.022. Epub 2009 Oct 24.

PMID:
19857448
19.

Cross-reactive Antibodies against avian influenza virus A (H5N1).

Pichyangkul S, Jongkaewwattana A, Thitithanyanont A, Ekchariyawat P, Wiboon-ut S, Limsalakpetch A, Yongvanitchit K, Kum-Arb U, Mahanonda R, Utaisincharoen P, Sirisinha S, Mason CJ, Fukuda MM.

Emerg Infect Dis. 2009 Sep;15(9):1537-9. doi: 10.3201/eid1509.090471. No abstract available.

20.

Cigarette smoke extract modulates human beta-defensin-2 and interleukin-8 expression in human gingival epithelial cells.

Mahanonda R, Sa-Ard-Iam N, Eksomtramate M, Rerkyen P, Phairat B, Schaecher KE, Fukuda MM, Pichyangkul S.

J Periodontal Res. 2009 Aug;44(4):557-64. doi: 10.1111/j.1600-0765.2008.01153.x. Epub 2009 Mar 13.

PMID:
19438974
21.

Expression and function of Toll-like receptors on dendritic cells and other antigen presenting cells from non-human primates.

Ketloy C, Engering A, Srichairatanakul U, Limsalakpetch A, Yongvanitchit K, Pichyangkul S, Ruxrungtham K.

Vet Immunol Immunopathol. 2008 Sep 15;125(1-2):18-30. doi: 10.1016/j.vetimm.2008.05.001. Epub 2008 May 8.

PMID:
18571243
22.

Effects of IL-17 on human gingival fibroblasts.

Mahanonda R, Jitprasertwong P, Sa-Ard-Iam N, Rerkyen P, Charatkulangkun O, Jansisyanont P, Nisapakultorn K, Yongvanichit K, Pichyangkul S.

J Dent Res. 2008 Mar;87(3):267-72.

PMID:
18296612
23.

Preclinical evaluation of the safety and immunogenicity of a vaccine consisting of Plasmodium falciparum liver-stage antigen 1 with adjuvant AS01B administered alone or concurrently with the RTS,S/AS01B vaccine in rhesus primates.

Pichyangkul S, Kum-Arb U, Yongvanitchit K, Limsalakpetch A, Gettayacamin M, Lanar DE, Ware LA, Stewart VA, Heppner DG, Mettens P, Cohen JD, Ballou WR, Fukuda MM.

Infect Immun. 2008 Jan;76(1):229-38. Epub 2007 Oct 22.

24.

High susceptibility of human dendritic cells to avian influenza H5N1 virus infection and protection by IFN-alpha and TLR ligands.

Thitithanyanont A, Engering A, Ekchariyawat P, Wiboon-ut S, Limsalakpetch A, Yongvanitchit K, Kum-Arb U, Kanchongkittiphon W, Utaisincharoen P, Sirisinha S, Puthavathana P, Fukuda MM, Pichyangkul S.

J Immunol. 2007 Oct 15;179(8):5220-7.

25.

Expression of toll-like receptors on antigen-presenting cells in patients with falciparum malaria.

Loharungsikul S, Troye-Blomberg M, Amoudruz P, Pichyangkul S, Yongvanitchit K, Looareesuwan S, Mahakunkijcharoen Y, Sarntivijai S, Khusmith S.

Acta Trop. 2008 Jan;105(1):10-5. Epub 2007 Aug 9.

PMID:
17854755
26.

Relative levels of IL4 and IFN-gamma in complicated malaria: association with IL4 polymorphism and peripheral parasitemia.

Tangteerawatana P, Pichyangkul S, Hayano M, Kalambaheti T, Looareesuwan S, Troye-Blomberg M, Khusmith S.

Acta Trop. 2007 Mar;101(3):258-65. Epub 2007 Feb 23.

PMID:
17379175
27.

The effects of Porphyromonas gingivalis LPS and Actinobacillus actinomycetemcomitans LPS on human dendritic cells in vitro, and in a mouse model in vivo.

Mahanonda R, Pothiraksanon P, Sa-Ard-Iam N, Yamazaki K, Schifferle RE, Hirunpetcharat C, Yongvanichit K, Pichyangkul S.

Asian Pac J Allergy Immunol. 2006 Dec;24(4):223-8.

28.

Long-lasting protective immune response to the 19-kilodalton carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 in mice.

Jeamwattanalert P, Mahakunkijcharoen Y, Kittigul L, Mahannop P, Pichyangkul S, Hirunpetcharat C.

Clin Vaccine Immunol. 2007 Apr;14(4):342-7. Epub 2007 Feb 21.

29.

Toll-like receptors and their role in periodontal health and disease.

Mahanonda R, Pichyangkul S.

Periodontol 2000. 2007;43:41-55. Review. No abstract available.

PMID:
17214834
30.

IL-8 and IDO expression by human gingival fibroblasts via TLRs.

Mahanonda R, Sa-Ard-Iam N, Montreekachon P, Pimkhaokham A, Yongvanichit K, Fukuda MM, Pichyangkul S.

J Immunol. 2007 Jan 15;178(2):1151-7.

31.

Heterologous prime-boost immunization in rhesus macaques by two, optimally spaced particle-mediated epidermal deliveries of Plasmodium falciparum circumsporozoite protein-encoding DNA, followed by intramuscular RTS,S/AS02A.

Walsh DS, Gettayacamin M, Leitner WW, Lyon JA, Stewart VA, Marit G, Pichyangkul S, Gosi P, Tongtawe P, Kester KE, Holland CA, Kolodny N, Cohen J, Voss G, Ballou WR, Heppner DG Jr.

Vaccine. 2006 May 8;24(19):4167-78. Epub 2006 Mar 6.

PMID:
16574282
32.

Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.

Heppner DG Jr, Kester KE, Ockenhouse CF, Tornieporth N, Ofori O, Lyon JA, Stewart VA, Dubois P, Lanar DE, Krzych U, Moris P, Angov E, Cummings JF, Leach A, Hall BT, Dutta S, Schwenk R, Hillier C, Barbosa A, Ware LA, Nair L, Darko CA, Withers MR, Ogutu B, Polhemus ME, Fukuda M, Pichyangkul S, Gettyacamin M, Diggs C, Soisson L, Milman J, Dubois MC, Garçon N, Tucker K, Wittes J, Plowe CV, Thera MA, Duombo OK, Pau MG, Goudsmit J, Ballou WR, Cohen J.

Vaccine. 2005 Mar 18;23(17-18):2243-50. Review.

PMID:
15755604
33.

Pre-clinical evaluation of the malaria vaccine candidate P. falciparum MSP1(42) formulated with novel adjuvants or with alum.

Pichyangkul S, Gettayacamin M, Miller RS, Lyon JA, Angov E, Tongtawe P, Ruble DL, Heppner DG Jr, Kester KE, Ballou WR, Diggs CL, Voss G, Cohen JD, Walsh DS.

Vaccine. 2004 Sep 28;22(29-30):3831-40.

PMID:
15364429
34.

Immunostimulatory CpG oligodeoxynucleotide confers protection in a murine model of infection with Burkholderia pseudomallei.

Wongratanacheewin S, Kespichayawattana W, Intachote P, Pichyangkul S, Sermswan RW, Krieg AM, Sirisinha S.

Infect Immun. 2004 Aug;72(8):4494-502.

35.

Monocyte activation by Porphyromonas gingivalis LPS in aggressive periodontitis with the use of whole-blood cultures.

Mahanonda R, Sa-Ard-Iam N, Charatkulangkun O, Promsudthi A, Schifferle RE, Yongvanichit K, Pichyangkul S.

J Dent Res. 2004 Jul;83(7):540-5.

PMID:
15218043
36.

CpG DNA, liposome and refined antigen oral cholera vaccine.

Leelawongtawon R, Somroop S, Chaisri U, Tongtawe P, Chongsa-nguan M, Kalambaheti T, Tapchaisri P, Pichyangkul S, Sakolvaree Y, Kurazono H, Hayashi H, Chaicumpa W.

Asian Pac J Allergy Immunol. 2003 Dec;21(4):231-9.

PMID:
15198341
37.

Safety and immunogenicity of rts,s+trap malaria vaccine, formulated in the as02a adjuvant system, in infant rhesus monkeys.

Walsh DS, Pichyangkul S, Gettayacamin M, Tongtawe P, Siegrist CA, Hansukjariya P, Kester KE, Holland CA, Voss G, Cohen J, Stewart AV, Miller RS, Ballou WR, Heppner DG Jr.

Am J Trop Med Hyg. 2004 May;70(5):499-509.

PMID:
15155981
38.

Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathway.

Pichyangkul S, Yongvanitchit K, Kum-arb U, Hemmi H, Akira S, Krieg AM, Heppner DG, Stewart VA, Hasegawa H, Looareesuwan S, Shanks GD, Miller RS.

J Immunol. 2004 Apr 15;172(8):4926-33.

39.

A blunted blood plasmacytoid dendritic cell response to an acute systemic viral infection is associated with increased disease severity.

Pichyangkul S, Endy TP, Kalayanarooj S, Nisalak A, Yongvanitchit K, Green S, Rothman AL, Ennis FA, Libraty DH.

J Immunol. 2003 Nov 15;171(10):5571-8.

40.
41.

Generation of gingival T cell lines/clones specific with Porphyromonas gingivalis pulsed dendritic cells from periodontitis patients.

Aroonrerk N, Pichyangkul S, Yongvanitchit K, Wisetchang M, Sa-Ard-Iam N, Sirisinha S, Mahanonda R.

J Periodontal Res. 2003 Jun;38(3):262-8.

PMID:
12753363
42.

CpG ODN enhances uptake of bacteria by mouse macrophages.

Utaisincharoen P, Kespichayawattana W, Anuntagool N, Chaisuriya P, Pichyangkul S, Krieg AM, Sirisinha S.

Clin Exp Immunol. 2003 Apr;132(1):70-5.

43.

Upregulation of co-stimulatory molecule expression and dendritic cell marker (CD83) on B cells in periodontal disease.

Mahanonda R, Sa-Ard-Iam N, Yongvanitchit K, Wisetchang M, Ishikawa I, Nagasawa T, Walsh DS, Pichyangkul S.

J Periodontal Res. 2002 Jun;37(3):177-83.

PMID:
12113551
44.

CpG ODN activates NO and iNOS production in mouse macrophage cell line (RAW 264.7).

Utaisincharoen P, Anuntagool N, Chaisuriya P, Pichyangkul S, Sirisinha S.

Clin Exp Immunol. 2002 Jun;128(3):467-73.

45.

2nd meeting on novel adjuvants currently in/close to human clinical testing. World Health Organization-Organization Mondiale de la Santé Fondation Mérieux, Annecy, France, 5-7 June 2000.

Kenney RT, Regina Rabinovich N, Pichyangkul S, Price VL, Engers HD.

Vaccine. 2002 May 22;20(17-18):2155-63. No abstract available.

PMID:
12009267
46.

Isolation and characterization of rhesus blood dendritic cells using flow cytometry.

Pichyangkul S, Saengkrai P, Yongvanitchit K, Limsomwong C, Gettayacamin M, Walsh DS, Stewart VA, Ballou WR, Heppner DG.

J Immunol Methods. 2001 Jun 1;252(1-2):15-23.

PMID:
11334961
47.
48.

Whole blood cultures to assess the immunostimulatory activities of CpG oligodeoxynucleotides.

Pichyangkul S, Yongvanitchit K, Kum-arb U, Krieg AM, Heppner DG, Walsh DS.

J Immunol Methods. 2001 Jan 1;247(1-2):83-94.

PMID:
11150539
49.

The immune modulation of B-cell responses by Porphyromonas ginginvalis and interleukin-10.

Champaiboon C, Yongvanitchit K, Pichyangkul S, Mahanonda R.

J Periodontol. 2000 Mar;71(3):468-75.

PMID:
10776936
50.

Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever.

Green S, Pichyangkul S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Nisalak A, Kurane I, Rothman AL, Ennis FA.

J Infect Dis. 1999 Nov;180(5):1429-35.

PMID:
10515800

Supplemental Content

Loading ...
Support Center